Global Drug Safety Testing Market Research Report 2026(Status and Outlook)
The drug safety testing service is a commercial service that helps pharmaceutical companies and other companies to conduct drug component analysis and safety testingThe global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Drug Safety Testing market size was estimated at USD 8553.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug Safety Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug Safety Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Safety Testing market.
Global Drug Safety Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ArisGlobal LLC
Eurofins
Clario
Charles River
Pace Analytical Services
LabCorp
ICON plc.
Boston Analytical
Catalent
Parexel International Corporation
Altasciences
Hangzhou Huante Biotechnology Co., Ltd.
Boende Testing
Microspectroscopy Technology Co., Ltd.
Pharmaron
JOINN
Shanghai InnoStar Bio-tech Co., Ltd
WESTCHINA-FRONTIE PHARMA TECH
Shanghai Medicilon
Hangzhou Rongchuang Biological Co., Ltd.
WuXi AppTec
Market Segmentation (by Type)
Drug Testing
Drug Analysis
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Medical Device Manufacturer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Safety Testing Market
Overview of the regional outlook of the Drug Safety Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Safety Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Safety Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Drug Safety Testing market size was estimated at USD 8553.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug Safety Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug Safety Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Safety Testing market.
Global Drug Safety Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ArisGlobal LLC
Eurofins
Clario
Charles River
Pace Analytical Services
LabCorp
ICON plc.
Boston Analytical
Catalent
Parexel International Corporation
Altasciences
Hangzhou Huante Biotechnology Co., Ltd.
Boende Testing
Microspectroscopy Technology Co., Ltd.
Pharmaron
JOINN
Shanghai InnoStar Bio-tech Co., Ltd
WESTCHINA-FRONTIE PHARMA TECH
Shanghai Medicilon
Hangzhou Rongchuang Biological Co., Ltd.
WuXi AppTec
Market Segmentation (by Type)
Drug Testing
Drug Analysis
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Medical Device Manufacturer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Safety Testing Market
Overview of the regional outlook of the Drug Safety Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Safety Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Safety Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Safety Testing
1.2 Key Market Segments
1.2.1 Drug Safety Testing Segment by Type
1.2.2 Drug Safety Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG SAFETY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG SAFETY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug Safety Testing Product Life Cycle
3.3 Global Drug Safety Testing Revenue Market Share by Company (2020-2025)
3.4 Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Drug Safety Testing Market Competitive Situation and Trends
3.6.1 Drug Safety Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug Safety Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG SAFETY TESTING VALUE CHAIN ANALYSIS
4.1 Drug Safety Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG SAFETY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Safety Testing Market Porter's Five Forces Analysis
6 DRUG SAFETY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Safety Testing Market by Type (2020-2025)
6.3 Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
7 DRUG SAFETY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Safety Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
8 DRUG SAFETY TESTING MARKET SEGMENTATION BY REGION
8.1 Global Drug Safety Testing Market Size by Region
8.1.1 Global Drug Safety Testing Market Size by Region
8.1.2 Global Drug Safety Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Safety Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Safety Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Safety Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Safety Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Safety Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArisGlobal LLC
9.1.1 ArisGlobal LLC Basic Information
9.1.2 ArisGlobal LLC Drug Safety Testing Product Overview
9.1.3 ArisGlobal LLC Drug Safety Testing Product Market Performance
9.1.4 ArisGlobal LLC SWOT Analysis
9.1.5 ArisGlobal LLC Business Overview
9.1.6 ArisGlobal LLC Recent Developments
9.2 Eurofins
9.2.1 Eurofins Basic Information
9.2.2 Eurofins Drug Safety Testing Product Overview
9.2.3 Eurofins Drug Safety Testing Product Market Performance
9.2.4 Eurofins SWOT Analysis
9.2.5 Eurofins Business Overview
9.2.6 Eurofins Recent Developments
9.3 Clario
9.3.1 Clario Basic Information
9.3.2 Clario Drug Safety Testing Product Overview
9.3.3 Clario Drug Safety Testing Product Market Performance
9.3.4 Clario SWOT Analysis
9.3.5 Clario Business Overview
9.3.6 Clario Recent Developments
9.4 Charles River
9.4.1 Charles River Basic Information
9.4.2 Charles River Drug Safety Testing Product Overview
9.4.3 Charles River Drug Safety Testing Product Market Performance
9.4.4 Charles River Business Overview
9.4.5 Charles River Recent Developments
9.5 Pace Analytical Services
9.5.1 Pace Analytical Services Basic Information
9.5.2 Pace Analytical Services Drug Safety Testing Product Overview
9.5.3 Pace Analytical Services Drug Safety Testing Product Market Performance
9.5.4 Pace Analytical Services Business Overview
9.5.5 Pace Analytical Services Recent Developments
9.6 LabCorp
9.6.1 LabCorp Basic Information
9.6.2 LabCorp Drug Safety Testing Product Overview
9.6.3 LabCorp Drug Safety Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 ICON plc.
9.7.1 ICON plc. Basic Information
9.7.2 ICON plc. Drug Safety Testing Product Overview
9.7.3 ICON plc. Drug Safety Testing Product Market Performance
9.7.4 ICON plc. Business Overview
9.7.5 ICON plc. Recent Developments
9.8 Boston Analytical
9.8.1 Boston Analytical Basic Information
9.8.2 Boston Analytical Drug Safety Testing Product Overview
9.8.3 Boston Analytical Drug Safety Testing Product Market Performance
9.8.4 Boston Analytical Business Overview
9.8.5 Boston Analytical Recent Developments
9.9 Catalent
9.9.1 Catalent Basic Information
9.9.2 Catalent Drug Safety Testing Product Overview
9.9.3 Catalent Drug Safety Testing Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Parexel International Corporation
9.10.1 Parexel International Corporation Basic Information
9.10.2 Parexel International Corporation Drug Safety Testing Product Overview
9.10.3 Parexel International Corporation Drug Safety Testing Product Market Performance
9.10.4 Parexel International Corporation Business Overview
9.10.5 Parexel International Corporation Recent Developments
9.11 Altasciences
9.11.1 Altasciences Basic Information
9.11.2 Altasciences Drug Safety Testing Product Overview
9.11.3 Altasciences Drug Safety Testing Product Market Performance
9.11.4 Altasciences Business Overview
9.11.5 Altasciences Recent Developments
9.12 Hangzhou Huante Biotechnology Co., Ltd.
9.12.1 Hangzhou Huante Biotechnology Co., Ltd. Basic Information
9.12.2 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Overview
9.12.3 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Market Performance
9.12.4 Hangzhou Huante Biotechnology Co., Ltd. Business Overview
9.12.5 Hangzhou Huante Biotechnology Co., Ltd. Recent Developments
9.13 Boende Testing
9.13.1 Boende Testing Basic Information
9.13.2 Boende Testing Drug Safety Testing Product Overview
9.13.3 Boende Testing Drug Safety Testing Product Market Performance
9.13.4 Boende Testing Business Overview
9.13.5 Boende Testing Recent Developments
9.14 Microspectroscopy Technology Co., Ltd.
9.14.1 Microspectroscopy Technology Co., Ltd. Basic Information
9.14.2 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Overview
9.14.3 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Market Performance
9.14.4 Microspectroscopy Technology Co., Ltd. Business Overview
9.14.5 Microspectroscopy Technology Co., Ltd. Recent Developments
9.15 Pharmaron
9.15.1 Pharmaron Basic Information
9.15.2 Pharmaron Drug Safety Testing Product Overview
9.15.3 Pharmaron Drug Safety Testing Product Market Performance
9.15.4 Pharmaron Business Overview
9.15.5 Pharmaron Recent Developments
9.16 JOINN
9.16.1 JOINN Basic Information
9.16.2 JOINN Drug Safety Testing Product Overview
9.16.3 JOINN Drug Safety Testing Product Market Performance
9.16.4 JOINN Business Overview
9.16.5 JOINN Recent Developments
9.17 Shanghai InnoStar Bio-tech Co., Ltd
9.17.1 Shanghai InnoStar Bio-tech Co., Ltd Basic Information
9.17.2 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Overview
9.17.3 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Market Performance
9.17.4 Shanghai InnoStar Bio-tech Co., Ltd Business Overview
9.17.5 Shanghai InnoStar Bio-tech Co., Ltd Recent Developments
9.18 WESTCHINA-FRONTIE PHARMA TECH
9.18.1 WESTCHINA-FRONTIE PHARMA TECH Basic Information
9.18.2 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
9.18.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Market Performance
9.18.4 WESTCHINA-FRONTIE PHARMA TECH Business Overview
9.18.5 WESTCHINA-FRONTIE PHARMA TECH Recent Developments
9.19 Shanghai Medicilon
9.19.1 Shanghai Medicilon Basic Information
9.19.2 Shanghai Medicilon Drug Safety Testing Product Overview
9.19.3 Shanghai Medicilon Drug Safety Testing Product Market Performance
9.19.4 Shanghai Medicilon Business Overview
9.19.5 Shanghai Medicilon Recent Developments
9.20 Hangzhou Rongchuang Biological Co., Ltd.
9.20.1 Hangzhou Rongchuang Biological Co., Ltd. Basic Information
9.20.2 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Overview
9.20.3 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Market Performance
9.20.4 Hangzhou Rongchuang Biological Co., Ltd. Business Overview
9.20.5 Hangzhou Rongchuang Biological Co., Ltd. Recent Developments
9.21 WuXi AppTec
9.21.1 WuXi AppTec Basic Information
9.21.2 WuXi AppTec Drug Safety Testing Product Overview
9.21.3 WuXi AppTec Drug Safety Testing Product Market Performance
9.21.4 WuXi AppTec Business Overview
9.21.5 WuXi AppTec Recent Developments
10 DRUG SAFETY TESTING MARKET FORECAST BY REGION
10.1 Global Drug Safety Testing Market Size Forecast
10.2 Global Drug Safety Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Safety Testing Market Size Forecast by Country
10.2.3 Asia Pacific Drug Safety Testing Market Size Forecast by Region
10.2.4 South America Drug Safety Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Drug Safety Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Drug Safety Testing Market Forecast by Type (2026-2035)
11.1.1 Global Drug Safety Testing Market Size Forecast by Type (2026-2035)
11.2 Global Drug Safety Testing Market Forecast by Application (2026-2035)
11.2.1 Global Drug Safety Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Safety Testing
1.2 Key Market Segments
1.2.1 Drug Safety Testing Segment by Type
1.2.2 Drug Safety Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG SAFETY TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG SAFETY TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug Safety Testing Product Life Cycle
3.3 Global Drug Safety Testing Revenue Market Share by Company (2020-2025)
3.4 Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Drug Safety Testing Market Competitive Situation and Trends
3.6.1 Drug Safety Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug Safety Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG SAFETY TESTING VALUE CHAIN ANALYSIS
4.1 Drug Safety Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG SAFETY TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Safety Testing Market Porter's Five Forces Analysis
6 DRUG SAFETY TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Safety Testing Market by Type (2020-2025)
6.3 Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
7 DRUG SAFETY TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Safety Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
8 DRUG SAFETY TESTING MARKET SEGMENTATION BY REGION
8.1 Global Drug Safety Testing Market Size by Region
8.1.1 Global Drug Safety Testing Market Size by Region
8.1.2 Global Drug Safety Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Safety Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Safety Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Safety Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Safety Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Safety Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArisGlobal LLC
9.1.1 ArisGlobal LLC Basic Information
9.1.2 ArisGlobal LLC Drug Safety Testing Product Overview
9.1.3 ArisGlobal LLC Drug Safety Testing Product Market Performance
9.1.4 ArisGlobal LLC SWOT Analysis
9.1.5 ArisGlobal LLC Business Overview
9.1.6 ArisGlobal LLC Recent Developments
9.2 Eurofins
9.2.1 Eurofins Basic Information
9.2.2 Eurofins Drug Safety Testing Product Overview
9.2.3 Eurofins Drug Safety Testing Product Market Performance
9.2.4 Eurofins SWOT Analysis
9.2.5 Eurofins Business Overview
9.2.6 Eurofins Recent Developments
9.3 Clario
9.3.1 Clario Basic Information
9.3.2 Clario Drug Safety Testing Product Overview
9.3.3 Clario Drug Safety Testing Product Market Performance
9.3.4 Clario SWOT Analysis
9.3.5 Clario Business Overview
9.3.6 Clario Recent Developments
9.4 Charles River
9.4.1 Charles River Basic Information
9.4.2 Charles River Drug Safety Testing Product Overview
9.4.3 Charles River Drug Safety Testing Product Market Performance
9.4.4 Charles River Business Overview
9.4.5 Charles River Recent Developments
9.5 Pace Analytical Services
9.5.1 Pace Analytical Services Basic Information
9.5.2 Pace Analytical Services Drug Safety Testing Product Overview
9.5.3 Pace Analytical Services Drug Safety Testing Product Market Performance
9.5.4 Pace Analytical Services Business Overview
9.5.5 Pace Analytical Services Recent Developments
9.6 LabCorp
9.6.1 LabCorp Basic Information
9.6.2 LabCorp Drug Safety Testing Product Overview
9.6.3 LabCorp Drug Safety Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 ICON plc.
9.7.1 ICON plc. Basic Information
9.7.2 ICON plc. Drug Safety Testing Product Overview
9.7.3 ICON plc. Drug Safety Testing Product Market Performance
9.7.4 ICON plc. Business Overview
9.7.5 ICON plc. Recent Developments
9.8 Boston Analytical
9.8.1 Boston Analytical Basic Information
9.8.2 Boston Analytical Drug Safety Testing Product Overview
9.8.3 Boston Analytical Drug Safety Testing Product Market Performance
9.8.4 Boston Analytical Business Overview
9.8.5 Boston Analytical Recent Developments
9.9 Catalent
9.9.1 Catalent Basic Information
9.9.2 Catalent Drug Safety Testing Product Overview
9.9.3 Catalent Drug Safety Testing Product Market Performance
9.9.4 Catalent Business Overview
9.9.5 Catalent Recent Developments
9.10 Parexel International Corporation
9.10.1 Parexel International Corporation Basic Information
9.10.2 Parexel International Corporation Drug Safety Testing Product Overview
9.10.3 Parexel International Corporation Drug Safety Testing Product Market Performance
9.10.4 Parexel International Corporation Business Overview
9.10.5 Parexel International Corporation Recent Developments
9.11 Altasciences
9.11.1 Altasciences Basic Information
9.11.2 Altasciences Drug Safety Testing Product Overview
9.11.3 Altasciences Drug Safety Testing Product Market Performance
9.11.4 Altasciences Business Overview
9.11.5 Altasciences Recent Developments
9.12 Hangzhou Huante Biotechnology Co., Ltd.
9.12.1 Hangzhou Huante Biotechnology Co., Ltd. Basic Information
9.12.2 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Overview
9.12.3 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Market Performance
9.12.4 Hangzhou Huante Biotechnology Co., Ltd. Business Overview
9.12.5 Hangzhou Huante Biotechnology Co., Ltd. Recent Developments
9.13 Boende Testing
9.13.1 Boende Testing Basic Information
9.13.2 Boende Testing Drug Safety Testing Product Overview
9.13.3 Boende Testing Drug Safety Testing Product Market Performance
9.13.4 Boende Testing Business Overview
9.13.5 Boende Testing Recent Developments
9.14 Microspectroscopy Technology Co., Ltd.
9.14.1 Microspectroscopy Technology Co., Ltd. Basic Information
9.14.2 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Overview
9.14.3 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Market Performance
9.14.4 Microspectroscopy Technology Co., Ltd. Business Overview
9.14.5 Microspectroscopy Technology Co., Ltd. Recent Developments
9.15 Pharmaron
9.15.1 Pharmaron Basic Information
9.15.2 Pharmaron Drug Safety Testing Product Overview
9.15.3 Pharmaron Drug Safety Testing Product Market Performance
9.15.4 Pharmaron Business Overview
9.15.5 Pharmaron Recent Developments
9.16 JOINN
9.16.1 JOINN Basic Information
9.16.2 JOINN Drug Safety Testing Product Overview
9.16.3 JOINN Drug Safety Testing Product Market Performance
9.16.4 JOINN Business Overview
9.16.5 JOINN Recent Developments
9.17 Shanghai InnoStar Bio-tech Co., Ltd
9.17.1 Shanghai InnoStar Bio-tech Co., Ltd Basic Information
9.17.2 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Overview
9.17.3 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Market Performance
9.17.4 Shanghai InnoStar Bio-tech Co., Ltd Business Overview
9.17.5 Shanghai InnoStar Bio-tech Co., Ltd Recent Developments
9.18 WESTCHINA-FRONTIE PHARMA TECH
9.18.1 WESTCHINA-FRONTIE PHARMA TECH Basic Information
9.18.2 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
9.18.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Market Performance
9.18.4 WESTCHINA-FRONTIE PHARMA TECH Business Overview
9.18.5 WESTCHINA-FRONTIE PHARMA TECH Recent Developments
9.19 Shanghai Medicilon
9.19.1 Shanghai Medicilon Basic Information
9.19.2 Shanghai Medicilon Drug Safety Testing Product Overview
9.19.3 Shanghai Medicilon Drug Safety Testing Product Market Performance
9.19.4 Shanghai Medicilon Business Overview
9.19.5 Shanghai Medicilon Recent Developments
9.20 Hangzhou Rongchuang Biological Co., Ltd.
9.20.1 Hangzhou Rongchuang Biological Co., Ltd. Basic Information
9.20.2 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Overview
9.20.3 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Market Performance
9.20.4 Hangzhou Rongchuang Biological Co., Ltd. Business Overview
9.20.5 Hangzhou Rongchuang Biological Co., Ltd. Recent Developments
9.21 WuXi AppTec
9.21.1 WuXi AppTec Basic Information
9.21.2 WuXi AppTec Drug Safety Testing Product Overview
9.21.3 WuXi AppTec Drug Safety Testing Product Market Performance
9.21.4 WuXi AppTec Business Overview
9.21.5 WuXi AppTec Recent Developments
10 DRUG SAFETY TESTING MARKET FORECAST BY REGION
10.1 Global Drug Safety Testing Market Size Forecast
10.2 Global Drug Safety Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Safety Testing Market Size Forecast by Country
10.2.3 Asia Pacific Drug Safety Testing Market Size Forecast by Region
10.2.4 South America Drug Safety Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Drug Safety Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Drug Safety Testing Market Forecast by Type (2026-2035)
11.1.1 Global Drug Safety Testing Market Size Forecast by Type (2026-2035)
11.2 Global Drug Safety Testing Market Forecast by Application (2026-2035)
11.2.1 Global Drug Safety Testing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Safety Testing Market Size by Type (M USD)
Table 4. Global Drug Safety Testing Market Size by Application
Table 5. Drug Safety Testing Market Size Comparison by Region (M USD)
Table 6. Global Drug Safety Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Drug Safety Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Drug Safety Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Safety Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Drug Safety Testing Market Size by Type (M USD)
Table 22. Global Drug Safety Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Drug Safety Testing Market Share by Type (2020-2025)
Table 24. Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Drug Safety Testing Market Size by Application
Table 26. Global Drug Safety Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Drug Safety Testing Market Share by Application (2020-2025)
Table 28. Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Drug Safety Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 36. ArisGlobal LLC Basic Information
Table 37. ArisGlobal LLC Drug Safety Testing Product Overview
Table 38. ArisGlobal LLC Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. ArisGlobal LLC SWOT Analysis
Table 40. ArisGlobal LLC Business Overview
Table 41. ArisGlobal LLC Recent Developments
Table 42. Eurofins Basic Information
Table 43. Eurofins Drug Safety Testing Product Overview
Table 44. Eurofins Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Eurofins SWOT Analysis
Table 46. Eurofins Business Overview
Table 47. Eurofins Recent Developments
Table 48. Clario Basic Information
Table 49. Clario Drug Safety Testing Product Overview
Table 50. Clario Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Clario SWOT Analysis
Table 52. Clario Business Overview
Table 53. Clario Recent Developments
Table 54. Charles River Basic Information
Table 55. Charles River Drug Safety Testing Product Overview
Table 56. Charles River Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Charles River Business Overview
Table 58. Charles River Recent Developments
Table 59. Pace Analytical Services Basic Information
Table 60. Pace Analytical Services Drug Safety Testing Product Overview
Table 61. Pace Analytical Services Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Pace Analytical Services Business Overview
Table 63. Pace Analytical Services Recent Developments
Table 64. LabCorp Basic Information
Table 65. LabCorp Drug Safety Testing Product Overview
Table 66. LabCorp Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. LabCorp Business Overview
Table 68. LabCorp Recent Developments
Table 69. ICON plc. Basic Information
Table 70. ICON plc. Drug Safety Testing Product Overview
Table 71. ICON plc. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. ICON plc. Business Overview
Table 73. ICON plc. Recent Developments
Table 74. Boston Analytical Basic Information
Table 75. Boston Analytical Drug Safety Testing Product Overview
Table 76. Boston Analytical Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Boston Analytical Business Overview
Table 78. Boston Analytical Recent Developments
Table 79. Catalent Basic Information
Table 80. Catalent Drug Safety Testing Product Overview
Table 81. Catalent Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Catalent Business Overview
Table 83. Catalent Recent Developments
Table 84. Parexel International Corporation Basic Information
Table 85. Parexel International Corporation Drug Safety Testing Product Overview
Table 86. Parexel International Corporation Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Parexel International Corporation Business Overview
Table 88. Parexel International Corporation Recent Developments
Table 89. Altasciences Basic Information
Table 90. Altasciences Drug Safety Testing Product Overview
Table 91. Altasciences Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Altasciences Business Overview
Table 93. Altasciences Recent Developments
Table 94. Hangzhou Huante Biotechnology Co., Ltd. Basic Information
Table 95. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Overview
Table 96. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Hangzhou Huante Biotechnology Co., Ltd. Business Overview
Table 98. Hangzhou Huante Biotechnology Co., Ltd. Recent Developments
Table 99. Boende Testing Basic Information
Table 100. Boende Testing Drug Safety Testing Product Overview
Table 101. Boende Testing Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Boende Testing Business Overview
Table 103. Boende Testing Recent Developments
Table 104. Microspectroscopy Technology Co., Ltd. Basic Information
Table 105. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Overview
Table 106. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Microspectroscopy Technology Co., Ltd. Business Overview
Table 108. Microspectroscopy Technology Co., Ltd. Recent Developments
Table 109. Pharmaron Basic Information
Table 110. Pharmaron Drug Safety Testing Product Overview
Table 111. Pharmaron Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Pharmaron Business Overview
Table 113. Pharmaron Recent Developments
Table 114. JOINN Basic Information
Table 115. JOINN Drug Safety Testing Product Overview
Table 116. JOINN Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 117. JOINN Business Overview
Table 118. JOINN Recent Developments
Table 119. Shanghai InnoStar Bio-tech Co., Ltd Basic Information
Table 120. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Overview
Table 121. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Shanghai InnoStar Bio-tech Co., Ltd Business Overview
Table 123. Shanghai InnoStar Bio-tech Co., Ltd Recent Developments
Table 124. WESTCHINA-FRONTIE PHARMA TECH Basic Information
Table 125. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
Table 126. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 127. WESTCHINA-FRONTIE PHARMA TECH Business Overview
Table 128. WESTCHINA-FRONTIE PHARMA TECH Recent Developments
Table 129. Shanghai Medicilon Basic Information
Table 130. Shanghai Medicilon Drug Safety Testing Product Overview
Table 131. Shanghai Medicilon Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Shanghai Medicilon Business Overview
Table 133. Shanghai Medicilon Recent Developments
Table 134. Hangzhou Rongchuang Biological Co., Ltd. Basic Information
Table 135. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Overview
Table 136. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Hangzhou Rongchuang Biological Co., Ltd. Business Overview
Table 138. Hangzhou Rongchuang Biological Co., Ltd. Recent Developments
Table 139. WuXi AppTec Basic Information
Table 140. WuXi AppTec Drug Safety Testing Product Overview
Table 141. WuXi AppTec Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 142. WuXi AppTec Business Overview
Table 143. WuXi AppTec Recent Developments
Table 144. Global Drug Safety Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 145. North America Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Europe Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Asia Pacific Drug Safety Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Middle East and Africa Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Global Drug Safety Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 151. Global Drug Safety Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Safety Testing Market Size by Type (M USD)
Table 4. Global Drug Safety Testing Market Size by Application
Table 5. Drug Safety Testing Market Size Comparison by Region (M USD)
Table 6. Global Drug Safety Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Drug Safety Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Drug Safety Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Safety Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Drug Safety Testing Market Size by Type (M USD)
Table 22. Global Drug Safety Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Drug Safety Testing Market Share by Type (2020-2025)
Table 24. Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Drug Safety Testing Market Size by Application
Table 26. Global Drug Safety Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Drug Safety Testing Market Share by Application (2020-2025)
Table 28. Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Drug Safety Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Drug Safety Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Drug Safety Testing Market Size by Region (2020-2025) & (M USD)
Table 36. ArisGlobal LLC Basic Information
Table 37. ArisGlobal LLC Drug Safety Testing Product Overview
Table 38. ArisGlobal LLC Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. ArisGlobal LLC SWOT Analysis
Table 40. ArisGlobal LLC Business Overview
Table 41. ArisGlobal LLC Recent Developments
Table 42. Eurofins Basic Information
Table 43. Eurofins Drug Safety Testing Product Overview
Table 44. Eurofins Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Eurofins SWOT Analysis
Table 46. Eurofins Business Overview
Table 47. Eurofins Recent Developments
Table 48. Clario Basic Information
Table 49. Clario Drug Safety Testing Product Overview
Table 50. Clario Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Clario SWOT Analysis
Table 52. Clario Business Overview
Table 53. Clario Recent Developments
Table 54. Charles River Basic Information
Table 55. Charles River Drug Safety Testing Product Overview
Table 56. Charles River Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Charles River Business Overview
Table 58. Charles River Recent Developments
Table 59. Pace Analytical Services Basic Information
Table 60. Pace Analytical Services Drug Safety Testing Product Overview
Table 61. Pace Analytical Services Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Pace Analytical Services Business Overview
Table 63. Pace Analytical Services Recent Developments
Table 64. LabCorp Basic Information
Table 65. LabCorp Drug Safety Testing Product Overview
Table 66. LabCorp Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. LabCorp Business Overview
Table 68. LabCorp Recent Developments
Table 69. ICON plc. Basic Information
Table 70. ICON plc. Drug Safety Testing Product Overview
Table 71. ICON plc. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. ICON plc. Business Overview
Table 73. ICON plc. Recent Developments
Table 74. Boston Analytical Basic Information
Table 75. Boston Analytical Drug Safety Testing Product Overview
Table 76. Boston Analytical Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Boston Analytical Business Overview
Table 78. Boston Analytical Recent Developments
Table 79. Catalent Basic Information
Table 80. Catalent Drug Safety Testing Product Overview
Table 81. Catalent Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Catalent Business Overview
Table 83. Catalent Recent Developments
Table 84. Parexel International Corporation Basic Information
Table 85. Parexel International Corporation Drug Safety Testing Product Overview
Table 86. Parexel International Corporation Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Parexel International Corporation Business Overview
Table 88. Parexel International Corporation Recent Developments
Table 89. Altasciences Basic Information
Table 90. Altasciences Drug Safety Testing Product Overview
Table 91. Altasciences Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Altasciences Business Overview
Table 93. Altasciences Recent Developments
Table 94. Hangzhou Huante Biotechnology Co., Ltd. Basic Information
Table 95. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Overview
Table 96. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Hangzhou Huante Biotechnology Co., Ltd. Business Overview
Table 98. Hangzhou Huante Biotechnology Co., Ltd. Recent Developments
Table 99. Boende Testing Basic Information
Table 100. Boende Testing Drug Safety Testing Product Overview
Table 101. Boende Testing Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Boende Testing Business Overview
Table 103. Boende Testing Recent Developments
Table 104. Microspectroscopy Technology Co., Ltd. Basic Information
Table 105. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Overview
Table 106. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Microspectroscopy Technology Co., Ltd. Business Overview
Table 108. Microspectroscopy Technology Co., Ltd. Recent Developments
Table 109. Pharmaron Basic Information
Table 110. Pharmaron Drug Safety Testing Product Overview
Table 111. Pharmaron Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Pharmaron Business Overview
Table 113. Pharmaron Recent Developments
Table 114. JOINN Basic Information
Table 115. JOINN Drug Safety Testing Product Overview
Table 116. JOINN Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 117. JOINN Business Overview
Table 118. JOINN Recent Developments
Table 119. Shanghai InnoStar Bio-tech Co., Ltd Basic Information
Table 120. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Overview
Table 121. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Shanghai InnoStar Bio-tech Co., Ltd Business Overview
Table 123. Shanghai InnoStar Bio-tech Co., Ltd Recent Developments
Table 124. WESTCHINA-FRONTIE PHARMA TECH Basic Information
Table 125. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Overview
Table 126. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 127. WESTCHINA-FRONTIE PHARMA TECH Business Overview
Table 128. WESTCHINA-FRONTIE PHARMA TECH Recent Developments
Table 129. Shanghai Medicilon Basic Information
Table 130. Shanghai Medicilon Drug Safety Testing Product Overview
Table 131. Shanghai Medicilon Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Shanghai Medicilon Business Overview
Table 133. Shanghai Medicilon Recent Developments
Table 134. Hangzhou Rongchuang Biological Co., Ltd. Basic Information
Table 135. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Overview
Table 136. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 137. Hangzhou Rongchuang Biological Co., Ltd. Business Overview
Table 138. Hangzhou Rongchuang Biological Co., Ltd. Recent Developments
Table 139. WuXi AppTec Basic Information
Table 140. WuXi AppTec Drug Safety Testing Product Overview
Table 141. WuXi AppTec Drug Safety Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 142. WuXi AppTec Business Overview
Table 143. WuXi AppTec Recent Developments
Table 144. Global Drug Safety Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 145. North America Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Europe Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Asia Pacific Drug Safety Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Middle East and Africa Drug Safety Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Global Drug Safety Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 151. Global Drug Safety Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Drug Safety Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Safety Testing Market Size (M USD), 2025-2035
Figure 5. Global Drug Safety Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Safety Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drug Safety Testing Product Life Cycle
Figure 12. Global Drug Safety Testing Revenue Share by Company in 2025
Figure 13. Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drug Safety Testing Revenue in 2025
Figure 15. Value Chain Map of Drug Safety Testing
Figure 16. Global Drug Safety Testing Market PEST Analysis
Figure 17. Global Drug Safety Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Drug Safety Testing Market Share by Type
Figure 20. Market Share of Drug Safety Testing by Type (2020-2025)
Figure 21. Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug Safety Testing Market Share by Application
Figure 24. Global Drug Safety Testing Market Share by Application (2020-2025)
Figure 25. Global Drug Safety Testing Market Share by Application in 2024
Figure 26. Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Drug Safety Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Drug Safety Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Drug Safety Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Drug Safety Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Drug Safety Testing Market Share by Country in 2024
Figure 35. Germany Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Drug Safety Testing Market Size Market Share by Region in 2024
Figure 42. China Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 48. South America Drug Safety Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Drug Safety Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Drug Safety Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Drug Safety Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Drug Safety Testing Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Drug Safety Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Safety Testing Market Size (M USD), 2025-2035
Figure 5. Global Drug Safety Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Safety Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drug Safety Testing Product Life Cycle
Figure 12. Global Drug Safety Testing Revenue Share by Company in 2025
Figure 13. Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drug Safety Testing Revenue in 2025
Figure 15. Value Chain Map of Drug Safety Testing
Figure 16. Global Drug Safety Testing Market PEST Analysis
Figure 17. Global Drug Safety Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Drug Safety Testing Market Share by Type
Figure 20. Market Share of Drug Safety Testing by Type (2020-2025)
Figure 21. Global Drug Safety Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug Safety Testing Market Share by Application
Figure 24. Global Drug Safety Testing Market Share by Application (2020-2025)
Figure 25. Global Drug Safety Testing Market Share by Application in 2024
Figure 26. Global Drug Safety Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Drug Safety Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Drug Safety Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Drug Safety Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Drug Safety Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Drug Safety Testing Market Share by Country in 2024
Figure 35. Germany Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Drug Safety Testing Market Size Market Share by Region in 2024
Figure 42. China Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 48. South America Drug Safety Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Drug Safety Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Drug Safety Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Drug Safety Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Drug Safety Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Drug Safety Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Drug Safety Testing Market Share Forecast by Application (2026-2035)
